Table 1.
Baseline characteristics of patients
| Variable | TAC | 5FU | T + F | pa |
|---|---|---|---|---|
| Age (mean ± SD), years | 26.35 ± 6.11 | 27.55 ± 8.54 | 29.9 ± 10.19 | 0.41 |
| Sex, n (%) | ||||
| Female | 12 (60) | 10 (50) | 12 (60) | 0.76 |
| Male | 8 (40) | 10 (50) | 8 (40) | |
| Etiology, n (%) | ||||
| Infective | 12 (60) | 11 (55) | 14 (70) | 0.64 |
| Traumatic | 6 (30) | 5 (25) | 5 (25) | |
| Spontaneous | 2 (10) | 4 (20) | 1 (5) | |
| Region, n (%) | ||||
| Presternal | 11 (55) | 12 (60) | 9 (45) | 0.69 |
| Trunk | 5 (25) | 2 (10) | 7 (35) | |
| Extremities | 3 (15) | 4 (20) | 3 (15) | |
| Face | 1 (5) | 2 (10) | 1 (5) | |
a
All p-values were greater than 0.05 (no statistically significant difference).
5FU, 5-fluorouracil; TAC, triamcinolone acetonide.